6th Apr 2005 15:27
GlaxoSmithKline PLC06 April 2005 GlaxoSmithKline plc Executive Director's details Further to the announcement dated 26 October 2004, the following details for MrJulian Heslop are provided in accordance with the requirements of the FinancialServices Authority's Listing Rules on his appointment to the Board ofGlaxoSmithKline plc with effect from 1 April 2005. Mr Heslop has held no directorships of publicly quoted companies during the pastfive years. Mr Heslop has an interest in 17,547 Ordinary Shares of GlaxoSmithKline plc. Allof these Ordinary Shares were acquired prior to Mr Heslop taking up hisappointment to the Board of GlaxoSmithKline plc. Mr Heslop also has an interestin 365,719 Ordinary Shares arising from the grant of options under the Company'sshare option schemes, and 25,500 Ordinary Shares under the Company's PerformanceShare Plan, all of which were granted prior to his taking up his appointment asa director. Paragraph 6.F.2 (b) to (g) Financial Services Authority's Listing Rules Mr Heslop has no details to disclose in respect of paragraph 6.F.2 (b) to (g) ofthe Financial Services Authority's Listing Rules. S M Bicknell Company Secretary 6 April 2005 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline